# Exploring vagus nerve stimulation in postoperative delirium and dementia

**Authors:** Rachel M. Spicer, Peder S. Olofsson, Fiona E. Harrison

PMC · DOI: 10.1186/s42234-026-00200-4 · Bioelectronic Medicine · 2026-02-20

## TL;DR

This paper explores how stimulating the vagus nerve might reduce brain inflammation and cognitive decline after surgery.

## Contribution

The paper introduces percutaneous vagus nerve stimulation as a novel strategy to mitigate postoperative neuroinflammation and cognitive decline.

## Key findings

- Postoperative delirium is linked to long-term cognitive decline and Alzheimer’s Disease risk.
- Peripheral inflammation after surgery worsens neuroinflammation and amyloid pathology.
- Vagus nerve stimulation is proposed as a potential intervention to reduce these effects.

## Abstract

Microglial activation and neuroinflammation, important aspects of neurodegeneration and accumulation of amyloid-pathology, is often exacerbated by peripheral inflammation following surgical procedures. Subsequent postoperative delirium is a predictor for long-term cognitive decline and increased rick of Alzheimer’s Disease, and perioperative strategies to reduce inflammatory responses, may be a potential avenue to mitigate postoperative complications. In this issue of Bioelectronic Medicine, Song et al. utilize percutaneous vagus nerve stimulation (pVNS) as a potential novel avenue for the attenuation of neuroinflammation and postoperative cognitive decline, which we have discussed in this commentary.

## Linked entities

- **Diseases:** Alzheimer’s Disease (MONDO:0004975)

## Full-text entities

- **Genes:** Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}
- **Diseases:** fever (MESH:D005334), sepsis (MESH:D018805), cognitive decline (MESH:D003072), Postoperative delirium (MESH:D000071257), Dementias (MESH:D003704), amyloid (MESH:C000718787), DSD (MESH:D003693), postoperative complications (MESH:D011183), Mental Disorders (MESH:D001523), agitation (MESH:D011595), AD (MESH:D000544), neuroinflammation (MESH:D000090862), lethargy (MESH:D053609), endotoxemia (MESH:D019446), inflammation (MESH:D007249), neurodegeneration (MESH:D019636), physical illness (MESH:D059445), disturbance of consciousness (MESH:D003244)
- **Chemicals:** Parecoxib (MESH:C409945), LPS (MESH:D008070), Dexmedetomidine (MESH:D020927), non-steroidal anti-inflammatory (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922289/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922289/full.md

---
Source: https://tomesphere.com/paper/PMC12922289